Skip to main content
. 2024 Nov 30;14(23):2705. doi: 10.3390/diagnostics14232705

Table 1.

Comparison of clinical background between patients with arterial occlusive AMI and non-AMI groups.

Arterial Occlusive AMI (n = 231) Non-AMI (n = 287) p-Value
Age, years (median, IQR) 71 (60–80) 69 (56–59) 0.14
Female gender (%) 100 (43.3) 138/284 (48.6) 0.23
Body Mass Index, kg/m2 (median, IQR) 24.4 (21.3–27.7) (n = 180) 24.7 (22.0–27.7) (n = 216) 0.56
Disability (%) 49/219 (22.4) 75/269 (27.9) 0.11
Current smoking (%) 70/180 (38.9) 51/225 (22.7) <0.001
Atrial fibrillation (%) 84 (36.4) 65 (22.6) <0.001
Atherosclerotic disease (%) 100/217 (46.1) 96/269 (35.7) 0.020
Hypertension (%) 166/224 (74.1) 169/280 (60.4) 0.001
Myocardial infarction (%) 48/221 (21.7) 33/274 (12.0) 0.004
Previous thromboembolic arterial event (%) 25/202 (12.4) 12/272 (4.4) 0.003
Charlson comorbidity index (median, IQR) 4 (3–6) (n = 212) 4 (2–5) (n = 268) 0.029
Anticoagulant drugs (%) 70/217 (32.3) 56/270 (20.7) 0.004
Antiplatelet drugs (%) 77/212 (36.3) 76/271 (28.0) 0.052
Statins (%) 76/213 (35.7) 85/270 (31.5) 0.33

AMI; acute mesenteric ischemia, IQR; interquartile range.